"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...
Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...
Getting ready for a Selenium interview after five years in the field can feel overwhelming. There’s a lot to remember—frameworks, real-world bugs, and all those tricky locator problems. If you’re ...
Fitness band maker Whoop formally opened Whoop Advanced Labs for business on Tuesday. Some 350,000 people were on the waitlist after the service was previewed in May, the company told TechCrunch.
In a college-entrance-exam landscape long dominated by the SAT and the ACT, a relative newcomer has started to gain traction—especially in red states. The Classic Learning Test, first unveiled a ...
On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...
Replimune (NASDAQ:REPL) announced on Tuesday that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter regarding its marketing application for its lead asset, RP1, declining ...
Replimune Group, Inc. (NASDAQ:REPL) stock plunged on Tuesday after a U.S. Food and Drug Administration (FDA) update. The clinical stage biotechnology company received an FDA Complete Response Letter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results